Model
Edge
Concert Pharmaceuticals, Inc.
0001367920
Filing Type
8-K
Filing Date
3/5/2023
Updated
3/6/23, 2:00 AM
Filing
8-K
Earnings Release
Exhibits
8-K
Completing Asset Acquisition or Sale, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modifications to Rights of Security Holders, Change in Company Ownership, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws
EX-2.2
EX-2.2
EX-3.1
EX-3.1